Novozymes AS (NVZMY)
Company Info
Highlights
$32.81B
$1.12
62.90
0.26
$9.91B
$4.50B
$1.84B
$53.42 - $72.03
$76.50
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Novozymes AS (NVZMY) returned 26.30% year-to-date (YTD) and 19.75% over the past 12 months. Over the past 10 years, NVZMY returned 5.50% annually, underperforming the S&P 500 benchmark at 10.85%.
NVZMY
26.30%
8.90%
21.55%
19.75%
5.47%
6.93%
5.50%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of NVZMY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.15% | 5.39% | -3.09% | 12.26% | 8.90% | 26.30% | |||||||
| 2024 | -7.24% | 10.72% | 4.38% | -6.34% | 8.88% | 2.28% | 4.34% | 8.65% | 4.47% | -12.87% | -6.36% | -3.76% | 3.97% |
| 2023 | 2.64% | -7.34% | 8.42% | 1.78% | -7.38% | -3.34% | 7.69% | -13.50% | -7.26% | 13.62% | 15.28% | 5.79% | 12.45% |
| 2022 | -17.59% | -4.95% | 6.81% | 1.41% | -8.72% | -5.47% | 6.47% | -10.44% | -12.56% | 4.70% | 10.29% | -12.68% | -38.46% |
| 2021 | 5.62% | 2.26% | 5.48% | 10.92% | 2.87% | 2.99% | 3.95% | 3.27% | -15.51% | 7.81% | 2.69% | 9.77% | 47.54% |
| 2020 | 6.41% | -0.86% | -10.31% | 7.06% | 12.38% | 5.66% | 2.63% | -0.67% | 6.76% | -4.19% | -5.32% | -0.04% | 18.70% |
| 2019 | -6.35% | 10.05% | 1.47% | 1.40% | 0.69% | -0.98% | -0.75% | -8.02% | -0.97% | 11.62% | 1.68% | 2.24% | 10.91% |
| 2018 | -2.70% | -7.79% | 3.58% | -10.52% | 8.95% | -1.15% | 4.26% | 4.13% | -0.02% | -10.02% | -5.43% | -3.93% | -20.53% |
| 2017 | 12.81% | 0.30% | 3.07% | 8.97% | 4.40% | -2.88% | 5.41% | 10.11% | 1.20% | 7.46% | -2.17% | 5.56% | 67.96% |
| 2016 | -12.85% | 4.53% | 4.41% | 5.92% | 0.07% | 1.05% | 2.49% | -12.22% | 2.61% | -16.67% | -8.86% | 2.43% | -26.83% |
| 2015 | 8.33% | 7.32% | -5.89% | 1.44% | 4.23% | -1.68% | 10.19% | -16.70% | -0.55% | 6.99% | 3.79% | -0.87% | 14.29% |
| 2014 | 2.39% | 8.41% | -5.35% | 8.55% | 2.82% | 2.50% | -1.70% | -6.46% | -6.49% | 7.08% | -4.67% | -4.53% | 0.71% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of NVZMY is 69, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Novozymes AS (NVZMY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Novozymes AS provided a 1.29% dividend yield over the last twelve months, with an annual payout of $0.91 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.91 | $0.59 | $1.47 | $0.85 | $0.85 | $0.78 | $0.76 | $0.74 | $0.57 | $0.51 | $0.45 | $0.46 |
Dividend yield | 1.29% | 1.04% | 2.68% | 1.67% | 1.02% | 1.36% | 1.56% | 1.66% | 1.00% | 1.48% | 0.94% | 1.09% |
Monthly Dividends
The table displays the monthly dividend distributions for Novozymes AS. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.61 | $0.00 | $0.61 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.59 |
| 2023 | $0.00 | $0.00 | $0.88 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $1.47 |
| 2022 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 |
| 2021 | $0.00 | $0.00 | $0.85 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.85 |
| 2020 | $0.00 | $0.78 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.78 |
| 2019 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.76 |
| 2018 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.74 |
| 2017 | $0.00 | $0.57 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.57 |
| 2016 | $0.00 | $0.51 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.51 |
| 2015 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 |
| 2014 | $0.46 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.46 |
Dividend Yield & Payout
Dividend Yield
Novozymes AS has a dividend yield of 1.29%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Novozymes AS has a payout ratio of 2.17%, which is below the market average. This means Novozymes AS returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Novozymes AS. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Novozymes AS was 56.25%, occurring on Oct 27, 2008. Recovery took 354 trading sessions.
The current Novozymes AS drawdown is 9.13%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -56.25% | Aug 9, 2007 | 246 | Oct 27, 2008 | 354 | Jul 27, 2010 | 600 |
| -51.84% | Jan 3, 2022 | 438 | Oct 2, 2023 | — | — | — |
| -39.35% | Aug 6, 2015 | 340 | Dec 8, 2016 | 197 | Sep 21, 2017 | 537 |
| -31.17% | May 3, 2011 | 316 | Aug 2, 2012 | 126 | Feb 5, 2013 | 442 |
| -28.75% | Jan 8, 2018 | 413 | Aug 28, 2019 | 192 | Jun 3, 2020 | 605 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Novozymes AS over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Novozymes AS, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -100.0%.
Valuation
The Valuation section provides an overview of how Novozymes AS is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NVZMY, comparing it with other companies in the Specialty Chemicals industry. Currently, NVZMY has a P/E ratio of 62.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NVZMY compared to other companies in the Specialty Chemicals industry. NVZMY currently has a PEG ratio of 0.3. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NVZMY relative to other companies in the Specialty Chemicals industry. Currently, NVZMY has a P/S ratio of 8.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NVZMY in comparison with other companies in the Specialty Chemicals industry. Currently, NVZMY has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |